DrugPatentWatch Database Preview

NATROBA Drug Profile

  Purchase this report

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Natroba, and when can generic versions of Natroba launch?

Natroba is a drug marketed by Parapro Llc and is included in one NDA. There are three patents protecting this drug.

This drug has forty-eight patent family members in thirty countries.

The generic ingredient in NATROBA is spinosad. There is one drug master file entry for this compound. Two suppliers are listed for this compound. Additional details are available on the spinosad profile page.

Summary for NATROBA

International Patents:	48
US Patents:	3
Applicants:	1
NDAs:	1
Suppliers / Packagers:	2
Clinical Trials:	3
Formulation / Manufacturing:	see details
DailyMed Link:	NATROBA at DailyMed

Pharmacology for NATROBA

Drug Class

Pediculicide

US Patents and Regulatory Information for NATROBA

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Parapro Llc	NATROBA	spinosad	SUSPENSION;TOPICAL	022408-001	Jan 18, 2011		RX	Yes	Yes			Y
Parapro Llc	NATROBA	spinosad	SUSPENSION;TOPICAL	022408-001	Jan 18, 2011		RX	Yes	Yes			Y
Parapro Llc	NATROBA	spinosad	SUSPENSION;TOPICAL	022408-001	Jan 18, 2011		RX	Yes	Yes			Y

  Purchase this report

or, see our see our flat-rate plans

Expired US Patents for NATROBA

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Parapro Llc	NATROBA	spinosad	SUSPENSION;TOPICAL	022408-001	Jan 18, 2011

Non-Orange Book US Patents for NATROBA

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No.	Title	Estimated Patent Expiration
6,727,228	Pediculicidal and ovacidal treatment compositions and methods for killing head lice and their eggs

  Purchase this report

or, see our see our flat-rate plans

International Patents for NATROBA

Country	Document Number	Estimated Expiration
Hungary	0102482
Norway	20010014
Brazil	0201412
Japan	2010229147

Supplementary Protection Certificates for NATROBA

Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
50009	Netherlands		PRODUCT NAME: SPINOSAD, DESGEWENST IN DE VORM VAN EEN ZOUT; NATL. REGISTRATION NO/DATE: 12363 N 20020913; FIRST REGISTRATION: SE 4511 20020204
C0047	France		PRODUCT NAME: SPINOSAD; REGISTRATION NO/DATE IN FRANCE: 2060098 DU 20060628; REGISTRATION NO/DATE AT EEC: 9275/B DU 20011023
C/GB02/028	United Kingdom		PRODUCT NAME: SPINOSAD; REGISTERED: CH W 6020 20010313; UK 0714 20020227